Skip to content
Clinical Trials – home

Hospital Jerez de la Frontera

Verifiedinfo

Spain Carretera De La Ronda Circunvalacion S/n, 11407 Jerez De La Frontera, Spain

  • 51 trials recruiting
  • Non-small cell lung cancer · Asthma · Plasma cell myeloma
  • Adults and children

About Specializations

Hospital Jerez de la Frontera in Jerez De La Frontera, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Asthma, Plasma cell myeloma, Breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology – Advanced Solid Tumors

The Hospital Jerez de la Frontera is conducting research focused on advanced solid tumors within the broader field of neoplasms. The studies aim to assess new combination therapies for safety, tolerability, and antitumor activity.

  • Evaluation of safety and tolerability of novel drug combinations
  • Identification of optimal dosing regimens through dose‑optimization studies
  • Assessment of antitumor efficacy in patients with advanced cancers

With a team of 42 investigators, the site is advancing precision oncology by testing the investigational agent PF‑08634404 paired with partner compounds, seeking to improve outcomes for patients across Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Carretera De La Ronda Circunvalacion S/n11407 Jerez De La FronteraSpain
Recruiting now
51 trials
Conditions studied
74
Partner status
Verified

More sites in Jerez De La FronteraSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

123 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Bronchiectasis

Recruiting
Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Janssen Cilag International
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Revolution Medicines Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Eikon Therapeutics Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:SIGVOTATUG VEDOTIN
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.